Abstract:Objectives: To investigate whether the STK15 mRNA expression correlates with clinicopathologic features and the prognosis of HCC patients.Design and methods: Three hepatoma cell lines, two normal liver epithelial cell lines, hepatoma tissues, adjacent tumor tissues and normal liver tissues were obtained from 46 HCC patients. Semi-quantitative RT-PCR assays were performed to detect the expression of STK15 mRNA in above cell lines and tissues. Moreover, the expression of SIX 15 protein in hepatoma tissues, adjacent tumor tissues and normal liver tissues was also examined by immunohistochemical staining. Finally, correlations between STK15 mRNA expression and the clinicopathological features and prognosis of HCC patients were evaluated.Results: STK15 mRNA showed higher levels in hepatoma cell lines than in normal liver epithelial cell lines. Moreover, the mean levels of STK15 mRNA and protein expression showed statistical difference between tumor tissues, tumor adjacent tissues and normal liver tissues (P<0.01). By immunohistochemical analysis, we found that paraffin-embedded archival HCC tissues showed higher expression of STK15 than adjacent tumors and normal liver tissues. Furthermore, HCC patients with higher STK15 mRNA expression showed poorer prognosis than those with lower STK15 mRNA expression. The high level of STK15 mRNA expression was significantly correlated with tumor stage (P=0.0081), more frequent lymph node (P=0.0380) or hematogenous metastasis (P=0.0066), and a higher incidence of cancer-related death (P=0.0083). Furthermore, the disease-free survival (DFS) and overall survival (OS) rates of HCC patients with higher STK15 mRNA expression group(47.6% and 52.7%)were significantly lower than those of patients with low STK15 mRNA expression group (56.9% and 68.8%, P=0.0018 and 0.0047). Conclusions: STK15 mRNA might be a good marker for predicting the prognosis of HCC patients.Conclusions: STK15 mRNA might be a good marker for predicting the prognosis of HCC patients. (C) 2009 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Advances in the Study on STK15 Gene

Effects of STK15 Overexpression on Growth of Human Esophageal Carcinoma Cell Line KYSE150

[Study on STK15 gene abnormality and centrosomal amplification in laryngeal carcinoma].

STK15 gene overexpression, centrosomal amplification, and chromosomal instability in the absence of STK15 mutations in laryngeal carcinoma.

The Investigation of STK15 Gene Amplification and Overexpression in Laryngeal Squamous Cell Carcinoma

STK4 is a prognostic biomarker correlated with immune infiltrates in clear cell renal cell carcinoma

The Association of Serine/threonine Kinase 15 Gene Overexpression with the Proliferation of Gastric Cancer Cells

[Mitotic Arrest of Gastric Cancer Cells Induced by Silencing of STK15 Gene].

Synergistic Effects of STK15 Gene Polymorphisms and Endogenous Estrogen Exposure in the Risk of Breast Cancer

Expressions of STK15 and Ki67 Gene in Gastric Carcinomas

Frequent Alterations in the Expression of Serine/Threonine Kinases in Human Cancers

Stk10 Deficiency in Mice Promotes Tumor Growth by Dysregulating the Tumor Microenvironment

Expression of STK15 Gene and Chromosomal Instability in Laryngeal Carcinoma

STK15 Rs2273535 Polymorphism and Cancer Risk: a Meta-Analysis of 74,896 Subjects.

Protein Kinase STK24 Promotes Tumor Immune Evasion Via the AKT‐PD‐L1 Axis

Advances in Research of Ser/Thr Kinase Polo-Like Kinase 1

Relevance of STK11 Mutations Regarding Immune Cell Infiltration, Drug Sensitivity, and Cellular Processes in Lung Adenocarcinoma

Expression of Stk15 Mrna in Hepatocellular Carcinoma and Its Prognostic Significance

Inhibition of serine/threonine kinase 15 gene expression induces apoptosis of gastric cancer cells]

Effect of KIF15 as a promoter role in the progression of osteosarcoma based on TCGA database

STK17B promotes carcinogenesis and metastasis via AKT/GSK-3β/Snail signaling in hepatocellular carcinoma